SideQuest: How a Custom-Built Gamification Platform Can Improve Student Learning and Socialization
Applied Economics Education and Extension · 11.06.2026
DOI: 10.71162/aeee.779141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Economics Education and Extension, online erschienen am 11.06.2026. Verfasst von Chris Finaret und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Recognizing Generation Alpha’s affinity for gaming, the authors developed SideQuest, a digital platform that integrates video-game-style quests to improve course learning and foster socialization. Implemented across seven economics classes at Allegheny College, SideQuest assigned students to “guilds” and offered a diverse array of quests—ranging from in-class participation and out-of-class study activities to co-curricular involvement and intensive pre-exam “Battle Passes.” Analysis of usage data from 116 students revealed that most students engaged with the platform, with participation peaking just before midterms. A positive correlation was observed between quest completion and higher course grades, particularly when comparing Battle Pass questing to grades. Survey responses indicated that students perceived SideQuest to be beneficial for both academic achievement and socialization.
Zitieren
APA
Finaret, C., & Cirimele, J. (2026). SideQuest: How a Custom-Built Gamification Platform Can Improve Student Learning and Socialization. Applied Economics Education and Extension. https://doi.org/10.71162/aeee.779141
Vancouver
Finaret C, Cirimele J. SideQuest: How a Custom-Built Gamification Platform Can Improve Student Learning and Socialization. Applied Economics Education and Extension. 2026. doi:10.71162/aeee.779141
BibTeX
@article{Finaret2026,
author = {Finaret, Chris and Cirimele, Jesse},
title = {SideQuest: How a Custom-Built Gamification Platform Can Improve Student Learning and Socialization},
journal = {Applied Economics Education and Extension},
year = {2026},
doi = {10.71162/aeee.779141}
}
EUVIMED